Aroa Biosurgery (ASX: ARX) — Company Overview, News & Financial Data
Aroa Biosurgery is an Australian medical device company focused on innovative wound healing products.
Aroa Biosurgery
Aroa Biosurgery is a medical technology company that develops, manufactures, and commercializes extracellular matrix medical devices for soft tissue repair and complex wound management. Founded in New Zealand, the company utilizes its proprietary extracellular matrix platform technology, derived from ovine forearm tissue, to produce soft tissue bioscaffolds. Its product portfolio includes extracellular matrix solutions designed to improve the rate and quality of tissue healing in complex surgical wounds, chronic wounds, abdominal wall reconstruction, and vascular applications. The company distributes its products globally, with major commercial operations in North America and international healthcare markets.
Snapshot
Operations
Products and/or services of Aroa Biosurgery
- Endoform Restorative Bioscaffolds: Extracellular matrix bioscaffold products engineered for acute and chronic wound management, providing a structural tissue framework that supports cellular infiltration, tissue remodeling, and vascularization across clinical settings.
- Myriad Matrix Surgical Bioscaffolds: Soft tissue bioscaffold engineered for complex surgical reconstruction, deep soft tissue deficits, and trauma wounds, enabling vascular integration and cellular migration in inpatient and outpatient surgical procedures.
- Symphony Hybrid Bioscaffolds: Combination cellular and tissue matrix products integrating extracellular matrix technology with hyaluronic acid, designed to accelerate healing rates and support tissue closure in hard-to-heal chronic wounds.
- Myriad Morcells Powdered Bioscaffolds: Conformable particulate extracellular matrix bioscaffolds designed for irregular surgical cavities, tunneled wounds, and complex soft tissue deficits requiring intimate contact and rapid cellular infiltration in specialized surgical procedures.
- Myriad Meshed Fenestrated Bioscaffolds: Fenestrated surgical bioscaffold sheets designed to facilitate expansion and fluid drainage across large soft tissue defects during surgical repair, complex trauma management, and soft tissue reconstructive operations.
- Reinforced Bioscaffolds and Surgical Solutions: Tissue repair matrices engineered specifically for hernia repair and abdominal wall reconstruction, combining soft tissue bioscaffolds with reinforcing polymers to restore structural integrity in complex surgical sites.
Aroa Biosurgery executive team
- Dr. Brian Ward B.V.Sc, MBA(dist)Founder, CEO, MD & Executive Director
- Mr. James Agnew BCom, LLBCFO & Joint Company Secretary
- Mr. Rod Stanley M.Sc.Chief Operating Officer
- Ms. Yasmin Winchester B.Sc.Chief of Technical Operations
- Dr. Barnaby C.H. May Ph.D.Chief Scientific Officer
- Ms. Neetha Alex-KumarGeneral Counsel
- Mr. Frazer MurrayDirector of Global Marketing & Strategy
- Ms. Tracy Weimar BA, MBAJoint Company Secretary
- Mr. Adam Young Ph.D.Vice President of Medical Affairs